Skip to content

Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses

Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04254003
Enrollment
48
Registered
2020-02-05
Start date
2020-02-05
Completion date
2020-03-02
Last updated
2020-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Errors

Keywords

toric contact lens, daily disposable, silicone hydrogel contact lens, axis orientation, astigmatism

Brief summary

The purpose of this study is to evaluate the rotational behavior of DT1 Toric contact lenses.

Detailed description

This is a single visit, non-dispense study where subjects will be exposed to the test and control lenses for approximately 1 hour each.

Interventions

DEVICEDT1 Toric contact lenses

Delefilcon A contact lenses for the optical correction of astigmatism in people with healthy eyes with or without refractive ametropia (myopia or hyperopia)

DEVICEAO1DfA contact lenses

Senofilcon A contact lenses for the optical correction of astigmatism in people with healthy eyes with or without refractive ametropia (myopia or hyperopia)

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Current wearer of any commercial soft daily wear contact lens with at least 3 months of wearing experience with a minimum wearing time of 5 days per week and 8 hours per day. * Requiring contact lens (manifest refraction) of a cylindrical power of -0.75 to -2.50 diopter cylinder (DC). * Best corrected distance visual acuity 20/25 or better Snellen in each eye (as determined by manifest refraction at screening). * Willing to NOT use rewetting/lubricating drops at any time during the study. Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Any anterior segment infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the Investigator. * Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator. * History of refractive surgery or plan to have refractive surgery during the study or irregular cornea in either eye. * Eye injury in either eye within 12 weeks immediately prior to enrollment for this trial. Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Percent of DT1 toric lenses with axis orientation within ±30° from the intended axis, 10 min after lens insertionDay 1, 10 minutes after lens insertion, each productA slit lamp will be used to observe axis orientation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026